http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-20063821-L

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-18
filingDate 2006-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7db4e7d81d0e4797a0bdac593020c0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d91be58c48de0b1ff167faa4378e8f68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a15e757efd4ce78a6efc88f2a67fd3a0
publicationDate 2006-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NO-20063821-L
titleOfInvention Quinoline derivatives for use as mycobacterial inhibitors
abstract The present invention relates to novel substituted quinoline derivatives of general formula (I) useful in the treatment of mycobacterial diseases such as TB.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-341242-B1
priorityDate 2004-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457484072

Total number of triples: 18.